ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 288

$404K Total Retail Price of All Prescriptions

Rank: 118 out of 288

350 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 8,158 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 419 379 1 2
FUROSEMIDE 294 290 2 5
OMEPRAZOLE 278 266 3 3
POTASSIUM CHLORIDE 264 241 4 11
LOSARTAN POTASSIUM 254 246 5 16
NABUMETONE 238 211 6 108
PRAVASTATIN SODIUM 204 200 7 21
ATENOLOL 196 182 8 10
AMLODIPINE BESYLATE 188 168 9 6
WARFARIN SODIUM 174 169 10 9
METOPROLOL SUCCINATE 171 170 11 15
NEXIUM 165 153 12 43
METFORMIN HCL 164 148 13 12
LISINOPRIL 156 152 14 4
HYDROCODONE-ACETAMINOPHEN 142 142 S3 15 7
TESTOSTERONE ENANTHATE 133 115 S3 10 16 262
TRIAMTERENE-HCTZ 125 113 17 28
ATORVASTATIN CALCIUM 120 115 18 14
CRESTOR 120 120 18 26
RANITIDINE HCL 119 118 20 33
DILTIAZEM 24HR CD 115 115 21 75
HYDROCHLOROTHIAZIDE 113 99 22 13
PAROXETINE HCL 107 107 23 54
METOPROLOL TARTRATE 106 99 24 8
ESTRADIOL 103 103 R 25 282
WELCHOL 89 80 26 249
PANTOPRAZOLE SODIUM 89 89 26 42
ALLOPURINOL 88 76 28 23
LOSARTAN-HYDROCHLOROTHIAZIDE 87 82 29 55
FLUTICASONE PROPIONATE 81 73 30 41
BENICAR 80 80 31 151
DIOVAN 79 79 32 53
ISOSORBIDE MONONITRATE ER 78 78 33 35
SYNTHROID 77 76 34 63
TAMSULOSIN HCL 76 71 35 24
OXYBUTYNIN CHLORIDE 67 54 36 69
AMOXICILLIN 66 62 37 118
VENLAFAXINE HCL ER 64 19 38 94
CITALOPRAM HBR 64 58 38 18
LANTUS 61 46 40 31
DILTIAZEM ER 61 61 40 102
IRBESARTAN 61 58 40 199
FINASTERIDE 58 46 43 82
PREMARIN 57 46 R 44 143
DOXYCYCLINE HYCLATE 57 49 44 123
AZITHROMYCIN 57 54 44 49
PREDNISONE 55 48 47 30
NITROFURANTOIN 54 48 48 210
PREMPRO 51 47 R 49 351
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.